Journey Clinical

Journey Clinical

Private
New York City, New YorkHealthcare & Life Scienceshttps://journeyclinical.com

Last Round

Series A

Jan 24, 2023

Total Funding Raised

$11.5M

Company Overview

Journey Clinical is a healthtech company that provides a platform for licensed mental health professionals to deliver Psychedelic-Assisted Psychotherapy (PAP), starting with Ketamine-Assisted Psychotherapy (KAP).

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Telemedicine, Vertical SaaS

Business Model

B2B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Non-AI

Keywords

Ketamine-Assisted PsychotherapyKAPketamine therapypsychedelic-assisted psychotherapypsychedelic therapycollaborative care modeltherapist enablementmental health platformpsychedelic medicineB2B2C platformat-home ketamine therapytelehealththerapist membershippsychiatric medication managementpatient-therapist matching

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Journey Clinical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Journey Clinical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 24, 2023
SeedSep 17, 2021

Key People

Founding team and executive leadership

Myriam Barthes

Co-Founder COO

Founding Team

Jonathan Sabbagh

Co-founder CEO

Founding Team

Journey Clinical Investors

Notable investors and investment history

InvestorRounds
AlleyCorpSeries A
Able PartnersSeries A
Union Square VenturesSeries A
GaingelsSeries A
Lionheart VenturesSeed
Palo SantoSeed, Series A
Neo Kuma VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 15, 2025

    Offering in-person monitoring for Spravato® treatments.

  • Oct 15, 2025

    Will provide Ketamine-Assisted Psychotherapy (KAP) education for group members.

Journey Clinical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Journey Clinical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Journey Clinical's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range103
Year Founded2020
Last FundingJan 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.